These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 6337611)

  • 1. Placebo-controlled trial of mianserin and maprotiline in primary depressive illness: a preliminary report.
    Edwards JG; Goldie A
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):239S-248S. PubMed ID: 6337611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind trial comparing mianserin and maprotiline in depressed inpatients.
    Palha AP; Ferreira L; Abreu-Lima C; Ramalhão C; Fernandes R
    Clin Ther; 1985; 7(5):584-92. PubMed ID: 3902238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparison of mianserin and maprotiline in depressed medically ill elderly people.
    Schifano F; Garbin A; Renesto V; De Dominicis MG; Trinciarelli G; Silvestri A; Magni G
    Acta Psychiatr Scand; 1990 Mar; 81(3):289-94. PubMed ID: 2188479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mianserin, maprotiline and intracardiac conduction.
    Edwards JG; Goldie A
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):249S-254S. PubMed ID: 6824556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects on suicidal ideation of mianserin, maprotiline and amitriptyline.
    Montgomery S; Cronholm B; Asberg M; Montgomery DB
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):77S-80S. PubMed ID: 341948
    [No Abstract]   [Full Text] [Related]  

  • 6. Mianserin and maprotiline as compared to amitriptyline in severe endogenous depression. A new methodological approach to the clinical evaluation of the efficacy of antidepressants.
    Cording-Tömmel C; von Zerssen D
    Pharmacopsychiatria; 1982 Nov; 15(6):197-204. PubMed ID: 7156183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mianserin versus maprotiline in patients with a depressive syndrome.
    Indaco A; Orefice G; Carrieri P
    Acta Neurol (Napoli); 1984 Apr; 6(2):140-6. PubMed ID: 6741655
    [No Abstract]   [Full Text] [Related]  

  • 8. Mianserin, maprotiline and the electroencephalogram.
    Sedgwick EM; Edwards JG
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):255S-259S. PubMed ID: 6824557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled study of the efficacy and safety of mianserin and maprotiline in outpatients with major depression.
    Möller HJ; Riehl T; Dietzfelbinger T; Wernicke T
    Int Clin Psychopharmacol; 1991; 6(3):179-92. PubMed ID: 1806624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maprotiline versus imipramine and placebo in neurotic depression.
    van der Velde CD
    J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic superiority of maprotiline versus doxepin in geriatric depression.
    Gwirtsman HE; Ahles S; Halaris A; DeMet E; Hill MA
    J Clin Psychiatry; 1983 Dec; 44(12):449-53. PubMed ID: 6361005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled comparative trial of mianserin and diazepam in the treatment of anxiety states in psychiatric out-patients.
    Conti L; Pinder RM
    J Int Med Res; 1979; 7(4):285-9. PubMed ID: 385399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimipramine and maprotiline: antidepressant, anxiolytic, and cardiotoxic comparison.
    Pecknold JC; Familamiri P; McClure DJ; Elie R; Chang H
    J Clin Psychiatry; 1985 May; 46(5):166-71. PubMed ID: 2859273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind multicentre trial comparing the efficacy and side-effects of mianserin and chlorimipramine in depressed in- and outpatients.
    Pinder RM; Blum A; Stulemeijer SM; Barres M; Molczadzki M; Rigaud A; Charbaut J; Israel L; Kammerer T
    Int Pharmacopsychiatry; 1980; 15(4):218-27. PubMed ID: 7021447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind comparative trial with mianserin and amitriptyline in outpatients with major depressive disorders.
    Feighner JP; Jacobs RS; Jackson RE; Hendrickson G; Merideth CH; O'Meara PD
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):227S-237S. PubMed ID: 6337610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Double-blind comparison of the effects of a new tricyclic antidepressant (Lofepramine) and a tetracyclic antidepressant (maprotiline)].
    Obermair W; Pöldinger W
    Int Pharmacopsychiatry; 1977; 12(2):65-71. PubMed ID: 330440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled trial of maprotiline (Ludiomil) in depressed outpatients.
    McCallum P; Meares R
    Med J Aust; 1975 Sep; 2(10):392-3. PubMed ID: 1102877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-generation antidepressants as research tools--some preliminary findings with clomipramine and maprotiline.
    Ridges AP
    Postgrad Med J; 1977; 53 Suppl 4():24-9. PubMed ID: 341107
    [No Abstract]   [Full Text] [Related]  

  • 19. Cognitive and psychomotor effects of different antidepressants in the treatment of old age depression.
    Siegfried K; O'Connolly M
    Int Clin Psychopharmacol; 1986 Jul; 1(3):231-43. PubMed ID: 3549874
    [No Abstract]   [Full Text] [Related]  

  • 20. The antidepressant properties of mianserin and its effect on sleep.
    Smith AH; Naylor GJ
    Acta Psychiatr Belg; 1978; 78(5):813-26. PubMed ID: 375685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.